Biotech is back! Regulatory tailwinds, cheaper valuations, and Fed cut hopes are boosting ETFs like XBI and IBB. Is the ...

Stocks to Buy and Sell. Biotechnology ETF (NASDAQ:IBB) is one of the trending analyst calls. Jason Snipe, Founder and CIO of ...

BIB ETF is best suited for high-risk, active investors in the accumulation phase or retirees managing portfolios hands-on.

Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...

Virtus LifeSci Biotech Clinical Trials ETF BBC is probably on the radar for investors seeking momentum. The fund just hit a ...

Biopharma has finally begun catching up with the overall stock market, as shares of the top three biopharma exchange traded funds (ETFs) jumped well into double digits over the past six months.

The company aims to raise Rs 27.52 crore via public issue of 21.5 lakh shares at the upper price band. This is purely a fresh ...

Wellgistics Health (WGRX) soared 155% after a Datavault AI tie-up, stirring buzz around AI and healthcare ETFs.

For Indian pharmaceutical companies that already supply nearly half of all generic medicines sold in the US, the decision ...

Fintel reports that on October 30, 2025, Cantor Fitzgerald maintained coverage of Vanda Pharmaceuticals (NasdaqGM:VNDA) with ...

Fintel reports that on October 30, 2025, Piper Sandler maintained coverage of BridgeBio Pharma (NasdaqGS:BBIO) with a ...

Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Ram Selvaraju ...